Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto L Horenstein

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2005
Purification of clinical-grade monoclonal antibodies by chromatographic methodsAlberto L Horenstein, Ilaria Durelli, Fabio Malavasi
Physiological Reviews|March 31, 2021
CD38 in the age of COVID-19: a medical perspectiveAlberto L Horenstein, Angelo C Faini, Fabio Malavasi
Frontiers in Immunology|May 10, 2019
CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to TherapyAlberto L Horenstein, Cristiano Bracci, Fabio Morandi, et al.
Journal of Immunological Methods|April 2, 2003
Design and scaleup of downstream processing of monoclonal antibodies for cancer therapy: from research to clinical proof of principleAlberto L Horenstein, Federico Crivellin, Ada Funaro, et al.
Frontiers in Bioscience (Landmark Edition)|June 5, 2014
The ADP-ribosyl cyclases--the current evolutionary state of the ARCsEnza Ferrero, Nicola Lo Buono, Alberto L Horenstein, et al.
Oncoimmunology|May 10, 2019
Microvesicles expressing adenosinergic ectoenzymes and their potential role in modulating bone marrow infiltration by neuroblastoma cellsFabio Morandi, Danilo Marimpietri, Alberto L Horenstein, et al.
Journal of Cellular Biochemistry|May 23, 2014
Expression of P2X7 ATP receptor mediating the IL8 and CCL20 release in human periodontal ligament stem cellsOriana Trubiani, Alberto L Horenstein, Francesco Caciagli, et al.
Frontiers in Immunology|December 15, 2018
CD38: A Target for Immunotherapeutic Approaches in Multiple MyelomaFabio Morandi, Alberto L Horenstein, Federica Costa, et al.
Frontiers in Immunology|April 5, 2017
Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma NicheAntonella Chillemi, Valeria Quarona, Luca Antonioli, et al.
Blood|December 23, 2004
CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survivalSilvia Deaglio, Tiziana Vaisitti, Luciana Bergui, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2005
Purification of clinical-grade monoclonal antibodies by chromatographic methodsAlberto L Horenstein, Ilaria Durelli, Fabio Malavasi
Physiological Reviews|March 31, 2021
CD38 in the age of COVID-19: a medical perspectiveAlberto L Horenstein, Angelo C Faini, Fabio Malavasi
Frontiers in Immunology|May 10, 2019
CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to TherapyAlberto L Horenstein, Cristiano Bracci, Fabio Morandi, et al.
Journal of Immunological Methods|April 2, 2003
Design and scaleup of downstream processing of monoclonal antibodies for cancer therapy: from research to clinical proof of principleAlberto L Horenstein, Federico Crivellin, Ada Funaro, et al.
Frontiers in Bioscience (Landmark Edition)|June 5, 2014
The ADP-ribosyl cyclases--the current evolutionary state of the ARCsEnza Ferrero, Nicola Lo Buono, Alberto L Horenstein, et al.
Oncoimmunology|May 10, 2019
Microvesicles expressing adenosinergic ectoenzymes and their potential role in modulating bone marrow infiltration by neuroblastoma cellsFabio Morandi, Danilo Marimpietri, Alberto L Horenstein, et al.
Journal of Cellular Biochemistry|May 23, 2014
Expression of P2X7 ATP receptor mediating the IL8 and CCL20 release in human periodontal ligament stem cellsOriana Trubiani, Alberto L Horenstein, Francesco Caciagli, et al.
Frontiers in Immunology|December 15, 2018
CD38: A Target for Immunotherapeutic Approaches in Multiple MyelomaFabio Morandi, Alberto L Horenstein, Federica Costa, et al.
Frontiers in Immunology|April 5, 2017
Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma NicheAntonella Chillemi, Valeria Quarona, Luca Antonioli, et al.
Blood|December 23, 2004
CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survivalSilvia Deaglio, Tiziana Vaisitti, Luciana Bergui, et al.
Pageof 5